Last update May 14, 2021
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
达比加群 is Dabigatran etexilate in Chinese.
Is written in other languages:达比加群 is also known as
达比加群 belongs to these groups or families:
Main tradenames from several countries containing 达比加群 in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Amamanta of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
An oral thrombin inhibitor. It belongs to the group of so-called non–vitamin K oral anticoagulants (NOACs) or direct anticoagulants.
Used in the prevention of venous thromboembolism in orthopedic surgery and atrial fibrillation.
Oral administration in a daily dose.
It is excreted in breastmilk in clinically insignificant amounts (Ayuk 2020 & 2016).
Its low oral bioavailability (EMA 2018, Blech 2008) hinders transfer to infant plasma via breastmilk, except in premature infants and the immediate neonatal period when there may be increased intestinal permeability.
It is the oral anticoagulant with the lowest excretion in breast milk (Daei 2021).